The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...

The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people ...

Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of people who ...

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to ...

GLP-1 agonists, such as Ozempic, are “almost starting to look like wonder drugs,” one expert said. But do the benefits extend ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

Here's what doctors thing is behind personality changes caused by Ozempic and other GLP-1s and what you can do about it.

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...